national stem-cell therapy logo

Breakthrough in Muscular Dystrophy Treatment: FDA Approves Stem Cell Therapy from Myogenica

illustration of stem cells regenerating skeletal muscles

The fight against muscular dystrophy has taken a promising turn with the recent FDA approval of an Investigational New Drug (IND) application for MyoPAXon, a revolutionary stem cell-derived muscle stem cell product developed by Myogenica, a University of Minnesota startup. This landmark approval paves the way for a clinical trial aimed at treating patients with […]

$500,000 Awarded for Groundbreaking Duchenne Muscular Dystrophy Trial

Duchenne UK - Parent Project Muscular Dystrophy Logo

In a landmark announcement, Duchenne UK and Parent Project Muscular Dystrophy (PPMD) have committed $500,000 to a pioneering Phase 1 clinical trial aimed at evaluating the safety and tolerability of muscle progenitor cells in patients with Duchenne Muscular Dystrophy (DMD). This trial represents a significant advancement in the quest to find effective treatments for this […]

Stem Cells: Unleashing Hope for Unimaginable Healing

Hope For Healing - The Power Of Stem Cells

The video above is a comprehensive exploration of the potential of stem cells in treating various health conditions. The video highlights several groundbreaking stem cell trials and the transformative impact they have had on patients’ lives. Duchenne Muscular Dystrophy: The video begins with the story of Hunter Horkheimer, a young man diagnosed with Duchenne muscular […]